Wednesday, 20 July 2011

Symansis - Cell Signalling Science

Caltag Medsystems has been awarded the UK and ROI distributorship for Symansis.

Symansis was founded by a group of leading cancer research scientists from the UK, USA and New Zealand. The company is situated in modern facilities, with GMP manufacturing, in the South Island of New Zealand.

Symansis products are of particular use in drug discovery and in the analysis of the effects of potential drug compounds on the activation of intra-cellular kinases. Symansis also supply human cell expressed proteins complete with all the glycosylation moieties ensuring full physiological function. These proteins are of interest in the fields of inflammation, cardiovascular disease, obesity and cancer.

View the Symansis product range here.

No comments:

Post a Comment

Webmaster: AnnWebCom | Site design: Creative Copyright 2005-2015 Caltag-Medsystems Limited - all rights reserved